Back to Dividend Stocks
Roche Holding AG (ROP.SW) logo

Roche Holding AG

EURO STOXX 600
ROP.SW|Healthcare|Drug Manufacturers - General|CHF 315.30|P/E 20.2|MCap 250.9B|SIX

Last update: May 9, 2026 at 09:32

Dividend Safety Rating

76/ 100Safe

ROP.SW's dividend appears safe and well-supported. Strengths include a 60.5% earnings payout ratio & 59.1% fcf payout ratio. Areas of concern: 0 yrs dividend streak.

Based on 14 of 15 metrics

Strengths

  • Interest Coverage: 13.6xEarnings cover interest payments many times over.
  • Return on Equity: 37.3%Strong return on equity reflects efficient profit generation.
  • Operating Margin: 30.0%Healthy operating margin provides a wide buffer.

Risks

  • Dividend Streak: 0 yrsShort dividend history limits track-record signal.

Payout & Coverage

Safe
Earnings Payout Ratio
60.5%Safe
FCF Payout Ratio
59.1%Safe
CFO Payout Ratio
48.3%Safe
Interest Coverage
13.6xVery Safe

Balance Sheet

Safe
Net Debt / Total Assets
27.4%Safe
Current Ratio
1.4xCaution
Debt-to-Equity
87.6Safe

Profitability

Very Safe
Return on Equity
37.3%Very Safe
Operating Margin
30.0%Very Safe
Gross Margin
73.7%Very Safe
Profit Margin Stability
StableSafe

Dividend Track Record

Safe
Dividend Streak
0 yrsDanger
Dividend Cut
NoneVery Safe
5-Year Dividend CAGR
N/AN/A
Earnings Stability
GrowingVery Safe

About Roche Holding AG

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, Switzerland, operating primarily in the pharmaceuticals and diagnostics divisions worldwide, including Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. In pharmaceuticals, it develops innovative medicines targeting key therapeutic areas such as oncology including blood and solid tumors, anaemia, dermatology, haemophilia, inflammatory and autoimmune diseases, neurological disorders, ophthalmology, respiratory disorders, transplantation, haematology, infectious diseases, cardio-metabolic conditions, diabetes, neuroscience, rare diseases, and women's health. The diagnostics division provides in vitro tests for diseases like cancer, diabetes, hepatitis, human papillomavirus, and infectious conditions including Covid-19; diagnostic instruments; and digital health solutions. Roche Holding AG integrates pharma and diagnostics strengths to support patient journeys from prevention and screening through diagnosis, treatment, and monitoring, offering comprehensive healthcare solutions that enhance outcomes across hospitals, clinics, research settings, and consumers.

Dividend Overview

Dividend Yield

3.04%

Annual Dividend

CHF 9.80

Frequency

N/A

Payout Ratio

60.47%

FCF Payout Ratio

59.14%

Stock Price

CHF 315.30

52-Week Range

CHF 291.00 CHF 327.40

Earnings & Profitability

ROP.SW earnings per share and net profit margin

Key Dates

Last Ex-Dividend Date

March 12, 2026

Next Payment Date

Dividend Growth

3-Year Dividend CAGR

N/A

5-Year Dividend CAGR

N/A

10-Year Dividend CAGR

N/A

3-Year Total Growth

N/A

5-Year Total Growth

N/A

10-Year Total Growth

N/A

Income Calculator

ROP.SW Dividend Calculator

Total Investment

CHF 31,530.00

Annual Income

CHF 980.00

Quarterly Income

CHF 245.00

Monthly Income

CHF 81.67

Frequently Asked Questions

What is ROP.SW's current dividend yield?
Roche Holding AG (ROP.SW) currently has a dividend yield of 3.04%, based on a stock price of CHF 315.30 and an annual dividend of CHF 9.80.
When is ROP.SW's next dividend payment date?
ROP.SW's next ex-dividend date is 2026-03-12 and the next payment date is —. You must own the stock before the ex-dividend date to receive the upcoming payment.
How much does ROP.SW pay in dividends per year?
Roche Holding AG pays dividends unknown. Annual dividend data is not yet available.
Has ROP.SW been increasing its dividend?
Roche Holding AG has grown its dividend at a 5-year CAGR of —.
Is ROP.SW's dividend safe?
Roche Holding AG has a payout ratio of 60.47%. The payout ratio is moderate. Monitor earnings to ensure sustainability.
How is ROP.SW's Dividend Safety Rating calculated?
The Dividend Safety Rating evaluates Roche Holding AG's dividend sustainability across four categories: Payout & Coverage (30%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (30%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track ROP.SW Dividends with OnlyDividends

What will ROP.SW actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.